3 BioMed Stocks To Buy Now

 

Oncolytics Biotech Inc. (ONCY)

Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an immuno-oncology viral-agent for the treatment of solid tumors and hematological malignancies.

Virios Therapeutics, Inc. (VIRI)

Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. Its lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia.

Gamida Cell Ltd. (GMDA)

Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company’s lead product candidate is omidubicel, a cell therapy that is in Phase III studies in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in patients with severe aplastic anemia.

 
Trending Ideas
Featured Stocks On The Move
Daily Rundown
Top 3 Stocks in Leading Sectors

  • 3 Audio & Video Product Stocks To Buy Now

    Koss Corporation (KOSS) Koss Corporation designs and manufactures high-quality headphones, focusing on delivering superior sound performance. The company offers a range of products catering to audiophiles, professionals, and everyday users,... Read More

  • 3 Software Stocks To Buy Now

    Similarweb Ltd. (SMWB) Similarweb Ltd. provides a digital intelligence platform that offers insights into web traffic, online performance, and market trends. Businesses use its tools to optimize their online presence,... Read More

  • 3 Financial Transaction Service Stocks To Buy Now

    Global Blue Group Holding AG (GB) Global Blue Group Holding AG specializes in providing tax-free shopping and payment services for international shoppers. The company facilitates smooth refund processes and innovative... Read More

  • 3 Medical Stocks To Buy Now

    Qudian Inc. (QDDEL) Qudian Inc. operates a consumer finance platform in China, providing small loans and credit products to underserved consumers. The company leverages data analytics and technology to streamline... Read More

  • 3 Electric Power Stocks To Buy Now

    Empresa Distribuidora y Comercializadora Norte S.A. (EDN) Empresa Distribuidora y Comercializadora Norte S.A. (EDN) distributes electricity to Argentina’s Buenos Aires region. The company focuses on reliable energy supply, infrastructure upgrades,... Read More

  • 3 Investment Brokerage Stocks To Buy Now

    Robinhood Markets, Inc. (HOOD) Robinhood Markets, Inc. operates a financial services platform offering commission-free trading in stocks, ETFs, and cryptocurrencies. Known for its user-friendly mobile app, the company focuses on... Read More

  • 3 Consumer Service Stocks To Buy Now

    FAT Brands Inc. (FAT) FAT Brands Inc. is a global franchising company that develops and manages a portfolio of fast-casual and casual dining restaurant brands. Known for its diverse offerings,... Read More

  • 3 Safety Stocks To Buy Now

    Digimarc Corporation (DMRC) Digimarc Corporation develops innovative digital watermarking and content identification technologies. Its solutions enhance product packaging, digital media, and supply chain transparency, providing companies with tools for brand... Read More

© Copyright 2020 Investing is Inherently Risky - There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses.